{"id":"prs-regimen-v","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL3234035","moleculeType":"Small molecule","molecularWeight":"470.61"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"PRS Regimen V likely combines multiple first-line or second-line anti-tuberculosis agents to target Mycobacterium tuberculosis through different mechanisms, reducing bacterial load and preventing drug resistance. The specific composition and mechanism depend on the exact drugs included in the regimen, which is not publicly detailed in standard pharmaceutical databases.","oneSentence":"PRS Regimen V is a combination chemotherapy regimen designed to treat pulmonary tuberculosis through multi-drug antimycobacterial activity.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:03:15.549Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Pulmonary tuberculosis"}]},"trialDetails":[{"nctId":"NCT05278988","phase":"PHASE4","title":"A Study of Ultrashort PRS Regimen V in the Treatment of MDR-TB","status":"COMPLETED","sponsor":"Shanghai Pulmonary Hospital, Shanghai, China","startDate":"2021-04-01","conditions":"MDR-TB","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"PRS Regimen V","genericName":"PRS Regimen V","companyName":"Shanghai Pulmonary Hospital, Shanghai, China","companyId":"shanghai-pulmonary-hospital-shanghai-china","modality":"Small molecule","firstApprovalDate":"","aiSummary":"PRS Regimen V is a combination chemotherapy regimen designed to treat pulmonary tuberculosis through multi-drug antimycobacterial activity. Used for Pulmonary tuberculosis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}